C Bryson-Cahn, AM Beieler, JD Chan… - Open forum …, 2019 - academic.oup.com
We retrospectively evaluated off-label use of dalbavancin as secondary therapy in 32
patients with serious Staphylococcus aureus infections (endocarditis, osteomyelitis, septic …